Caricamento...
Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland
RATIONALE: There is limited evidence supporting the routine use of palivizumab in paediatric cystic fibrosis (CF) patients to reduce respiratory syncytial virus (RSV) infection and related hospitalisation. Despite this, anti-RSV prophylaxis is increasingly common. This is the first report from Irela...
Salvato in:
| Pubblicato in: | Multidiscip Respir Med |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607252/ https://ncbi.nlm.nih.gov/pubmed/26473032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40248-015-0029-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|